Cell Derived Extracellular Matrix BIofiber Engineering
细胞衍生的细胞外基质生物纤维工程
基本信息
- 批准号:2320185
- 负责人:
- 金额:$ 42.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Non-technical Abstract:Fibers are a highly versatile geometry that can be fabricated into a range of implant geometries (meshes, tubes, ropes) using manufacturing methods developed and routinely used by the textile industry. Unfortunately, synthetic fibers are recognized by the human body as a foreign material which makes them challenging to use as medical implants. As an alternative to synthetic fibers, the overall research goal of this project is to develop a fiber built using the molecules, like collagen, that are secreted by living cells. These all-natural biofibers would avoid the foreign material response directed by the body against synthetic polymeric materials, but could still be used with currently available textile fabrication techniques in order to make various medical products. More broadly, the proposed research could help establish a supply of materials that would help alleviate the shortage of donated human tissues and address the complications associated with medical implants that use synthetic fibers. To create these biofibers, the investigators will develop innovative methods to farm the molecules that are secreted by populations of cells during growth in the lab. Specifically, the investigators will create a toolbox of cell derived biofibers using key human cells and then explore methods to fabricate these human cell derived biofibers into beneficial medical implants. To enhance the broader impact of this study the research will be complemented by educational projects at the undergraduate and K-12 academic levels. Highlights include the creation of a rural biomedical engineering middle school summer program, the integration of fiber projects into the university courses, and the involvement of undergraduate students through participation in existing University programs.Technical Abstract: The investigators will develop biomaterial fibers that are built from the extracellular matrix (ECM) molecules secreted by cells. To do so the team will explore methods to farm the ECM that is secreted by populations of cells during growth in culture. While methods to collect isolated molecules from cells have existed for some time, the wholesale collection of cell secreted ECM proteins to create bulk biomaterials is unique. The overall goal is to fabricate woven biomedical implants using ECM as an alternative to synthetic polymer fibers. To collect the ECM that cells secrete, the investigators will utilize a solvent degradable hollow fiber membrane (HFM). When cells are seeded into the HFM and grown in culture they secrete a multitude of ECM molecules that accumulate within the lumen. The innovative step is that the HFM can be thoroughly dissolved using a water miscible solvent, stripping away the synthetic component, and leaving behind the accumulated ECM fiber. The result is a biofiber formed entirely from the ECM secreted by cells. The proposed research program will investigate the synthesis of next generation human ECM biofibers using clinically relevant cell types (cardiac, muscle, vascular); optimize synthesis methods and model the influence of pro-collagen synthesis schemes on ECM biofiber properties and identify combinations that optimize yield and mechanics; genetically engineer producer cells with specialized ECM production capabilities and examine the properties of ECM biofibers synthesized using them; characterize the in-vivo host response to implanted ECM biofibers, with particular attention given to inflammation and fibrotic tissue formation; and lastly create scaled-up biofiber manufacturing schemes and utilize textile production schemes to create woven biofiber constructs. To enhance the broader impact of this study the research will be complemented by integrated educational projects at the undergraduate and K-12 academic levels, both within the University of Arkansas and as educational outreach.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
非技术摘要:纤维是一种高度通用的几何形状,可以使用纺织行业开发和常规使用的制造方法制造成一系列植入物几何形状(网、管、绳)。不幸的是,合成纤维被人体识别为异物,这使得它们难以用作医疗植入物。作为合成纤维的替代品,该项目的总体研究目标是开发一种使用活细胞分泌的胶原蛋白等分子构建的纤维。这些全天然生物纤维将避免由身体针对合成聚合物材料的异物反应,但仍然可以与目前可用的纺织品制造技术一起使用,以制造各种医疗产品。更广泛地说,拟议的研究可以帮助建立一种材料供应,这将有助于缓解捐赠人体组织的短缺,并解决与使用合成纤维的医疗植入物相关的并发症。为了制造这些生物纤维,研究人员将开发创新方法来培养细胞群体在实验室生长过程中分泌的分子。具体来说,研究人员将使用关键的人类细胞创建细胞衍生生物纤维工具箱,然后探索将这些人类细胞衍生生物纤维制造成有益的医疗植入物的方法。为了提高这项研究的更广泛的影响,研究将在本科和K-12学术水平的教育项目的补充。重点包括创建农村生物医学工程中学暑期项目,将纤维项目融入大学课程,以及通过参与现有的大学课程让本科生参与进来。技术摘要:研究人员将开发由细胞分泌的细胞外基质(ECM)分子构建的生物材料纤维。为此,研究小组将探索培养细胞群体在培养过程中分泌的ECM的方法。虽然从细胞中收集分离分子的方法已经存在了一段时间,但批量收集细胞分泌的ECM蛋白以产生大量生物材料是独特的。 总体目标是使用ECM作为合成聚合物纤维的替代品来制造编织生物医学植入物。为了收集细胞分泌的ECM,研究人员将利用溶剂可降解的中空纤维膜(HFM)。当细胞被接种到HFM中并在培养物中生长时,它们分泌大量ECM分子,这些ECM分子在管腔内积累。创新的一步是,HFM可以使用水溶性溶剂彻底溶解,剥离合成成分,并留下积累的ECM纤维。结果是完全由细胞分泌的ECM形成的生物纤维。拟议的研究计划将调查使用临床相关细胞类型合成下一代人类ECM生物纤维(心脏、肌肉、血管);优化合成方法并模拟前胶原合成方案对ECM生物纤维性质的影响,并鉴定优化产率和力学的组合;对具有专门ECM生产能力的生产细胞进行基因工程改造,并检查使用它们合成的ECM生物纤维的性质;表征体内宿主对植入的ECM生物纤维的反应,特别关注炎症和纤维化组织形成;最后创建按比例放大的生物纤维制造方案,并利用纺织品生产方案来创建编织的生物纤维结构。为了提高这项研究的更广泛的影响,该研究将在本科和K-12学术水平的综合教育项目的补充,无论是在阿肯色州大学和教育推广。这个奖项反映了NSF的法定使命,并已被认为是值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Wolchok其他文献
Jeffrey Wolchok的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Wolchok', 18)}}的其他基金
The Response of Brain Cells to Traumatic Injury
脑细胞对创伤的反应
- 批准号:
1404716 - 财政年份:2014
- 资助金额:
$ 42.78万 - 项目类别:
Standard Grant
相似国自然基金
tRNA-derived small RNA上调YBX1/CCL5通路参与硼替佐米诱导慢性疼痛的机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
TET1/exosome-derived miR-22-3p/BTG1信号轴在膀胱癌化疗耐药中的作用与分子机制
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
一类DMOA-Derived Meroterpenoid的全合成研究
- 批准号:
- 批准年份:2020
- 资助金额:63 万元
- 项目类别:面上项目
基于肝炎病毒嗜肝性对hESC-derived hepatocytes 体外分化过程中的关键因子分析
- 批准号:81870432
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
hESC-derived hepatocytes 中抗HBV干扰素反应模式及关键ISGs 的功能分析
- 批准号:81570567
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Human heart explant-derived cell extracellular vesicles inhibit NLRP3 inflammasome activation in macrophages
人心脏外植体来源的细胞胞外囊泡抑制巨噬细胞中NLRP3炎症小体的活化
- 批准号:
480722 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain
细胞源性细胞外囊泡介导大脑中HIV的表观遗传沉默
- 批准号:
10748545 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Modelling cancer cell-derived extracellular vesicles using synthetic nanoparticles
使用合成纳米粒子模拟癌细胞衍生的细胞外囊泡
- 批准号:
479644 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Operating Grants
Regulation of Tendon Repair with Stem Cell-Derived Extracellular Vesicles
干细胞来源的细胞外囊泡对肌腱修复的调节
- 批准号:
10929503 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Extracellular vesicles (EVs) as a window into the depressed brain: an investigation of brain-cell derived EVs
细胞外囊泡(EV)作为了解抑郁大脑的窗口:对脑细胞衍生的 EV 的研究
- 批准号:
478501 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Operating Grants
The Function and Potential Application of Extracellular Vesicle Derived Clara Cell Protein 16 in Gram-negative Bacterial Pneumonia
细胞外囊泡衍生的 Clara 细胞蛋白 16 在革兰氏阴性细菌性肺炎中的功能和潜在应用
- 批准号:
10905165 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Alpha cell-derived Extracellular Vesicles and Maternal Insulin Production
α细胞来源的细胞外囊泡和母体胰岛素的产生
- 批准号:
10681939 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Roles of Red Blood Cell Derived Extracellular Vesicles in Complement Activation and Thromboinflammation in sickle cell disease
红细胞衍生的细胞外囊泡在镰状细胞病补体激活和血栓炎症中的作用
- 批准号:
10830199 - 财政年份:2023
- 资助金额:
$ 42.78万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 42.78万 - 项目类别:
Roles of Red Blood Cell Derived Extracellular Vesicles in Complement Activation and Thromboinflammation in Sickle Cell Disease
红细胞衍生的细胞外囊泡在镰状细胞病补体激活和血栓炎症中的作用
- 批准号:
10449795 - 财政年份:2022
- 资助金额:
$ 42.78万 - 项目类别: